These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1317639)

  • 1. Analysis of uterine contractility after administration of the non-steroidal anti-inflammatory drug nimesulide.
    Pulkkinen M; Monti T; Macciocchi A
    Acta Obstet Gynecol Scand; 1992 Apr; 71(3):181-5. PubMed ID: 1317639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of nimesulide and naproxen on the uterine and ovarian arterial blood flow velocity. A Doppler study.
    Pirhonen J; Pulkkinen M
    Acta Obstet Gynecol Scand; 1995 Aug; 74(7):549-53. PubMed ID: 7618455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nimesulide in dysmenorrhoea.
    Pulkkinen M
    Drugs; 1993; 46 Suppl 1():129-33. PubMed ID: 7506151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in intrauterine pressure, menstrual fluid prostaglandin F levels, and pain in dysmenorrheic women treated with nimesulide.
    Pulkkinen MO
    J Clin Pharmacol; 1987 Jan; 27(1):65-9. PubMed ID: 3680556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressure-velocity analysis of uterine muscle during spontaneous dysmenorrheic contractions in vivo.
    Smith RP
    Am J Obstet Gynecol; 1989 Jun; 160(6):1400-3; discussion 1403-5. PubMed ID: 2735366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an oral contraceptive on uterine tonicity in women with primary dysmenorrhea.
    Lalos O; Joelsson I
    Acta Obstet Gynecol Scand; 1981; 60(3):229-32. PubMed ID: 7270089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a vasopressin antagonist in women with dysmenorrhea.
    Valentin L; Sladkevicius P; Kindahl H; Broeders A; Marsal K; Melin P
    Gynecol Obstet Invest; 2000; 50(3):170-7. PubMed ID: 11014949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-uterine pressure in dysmenorrhea.
    Lumsden MA; Baird DT
    Acta Obstet Gynecol Scand; 1985; 64(2):183-6. PubMed ID: 3984694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandins and the non-pregnant uterus. The pathophysiology of primary dysmenorrhea.
    Pulkkinen MO
    Acta Obstet Gynecol Scand Suppl; 1983; 113():63-7. PubMed ID: 6344545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The myometrial response to intra-uterine administration of PGF2alpha and PGE2 in dysmenorrheic women.
    Lundström V
    Acta Obstet Gynecol Scand; 1977; 56(3):167-72. PubMed ID: 878858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nimesulide and indomethacin on contractility and the Ca2+ channel current in myometrial smooth muscle from pregnant women.
    Sawdy R; Knock GA; Bennett PR; Poston L; Aaronson PI
    Br J Pharmacol; 1998 Nov; 125(6):1212-7. PubMed ID: 9863649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the effect of high-intensity transcutaneous nerve stimulation and oral naproxen on intrauterine pressure and menstrual pain in patients with primary dysmenorrhea.
    Milsom I; Hedner N; Mannheimer C
    Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):123-9. PubMed ID: 8296814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of short-term, low-dose treatment with tamoxifen in patients with primary dysmenorrhea.
    Pierzyński P; Swiatecka J; Oczeretko E; Laudański P; Batra S; Laudański T
    Gynecol Endocrinol; 2006 Dec; 22(12):698-703. PubMed ID: 17162713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The objective evaluation of dysmenorrhea therapy.
    Smith RP; Powell JR
    Am J Obstet Gynecol; 1980 Jun; 137(3):314-9. PubMed ID: 6990763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution analysis of intrauterine pressure in nonpregnant dysmenorrheic women.
    Smith RP
    Am J Obstet Gynecol; 1984 Jun; 149(3):271-3. PubMed ID: 6731505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ge-Gen Decoction attenuates oxytocin-induced uterine contraction and writhing response: potential application in primary dysmenorrhea therapy.
    Yang L; Chai CZ; Yue XY; Yan Y; Kou JP; Cao ZY; Yu BY
    Chin J Nat Med; 2016 Feb; 14(2):124-132. PubMed ID: 26968678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaprox in dysmenorrhea: reduction of pain and intrauterine pressure.
    Henzl MR; Ortega-Herrera E; Rodriguez C; Izu A
    Am J Obstet Gynecol; 1979 Oct; 135(4):455-60. PubMed ID: 484644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandins, indomethacin and dysmenorrhea.
    Lundström V; Gréen K; Wiqvist N
    Prostaglandins; 1976 May; 11(5):893-907. PubMed ID: 935518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nimesulide in the treatment of primary dysmenorrhea. Comparative clinical evaluation with mefenamic acid and fentiazac].
    López Rosales C; Cisneros Lugo JH; Romo Enciso LJ; García Sandoval MG
    Ginecol Obstet Mex; 1989 Jul; 57():196-201. PubMed ID: 2486951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interrelation of analgesia and uterine activity in women with primary dysmenorrhea. A preliminary report.
    Smith RP; Heltzel JA
    J Reprod Med; 1991 Apr; 36(4):260-4. PubMed ID: 2072357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.